chrisvoncsefalvay/vaers-outcomes huggingface dataset:
April 16th one after the Phizer vaccination first shot I had numbness  and tingling in my gums, lips, and jawline.  I felt out of sorts similar to a heavy brain fog including confusion.  Legs were weak, I stumbled as I walked, motor skills significantly slowed.  Next tip of tongue numb and throat tightening.  Dizziness including spinning sensation.  Headache borderline migraine.  Went to ER  .  Intravenous treatment Benadryl and Pepcid.  I was instructed to continue taking Benadryl over the counter and Pepcid over the counter. and schedule  follow up  appointment with general practitioner. April 20th  GP advised to continue Benadryl and follow up with Neurologist and/or Physical Therapy if symptoms continue.   Afternoon of April 20th left jawline and lower face developed clear welts/hives.  Red cobblestone rash on neck, jawline and lower face.  GP on call prescribed Prednisone 20 mg instructions 2x for 3 days then 1x for three days.  April 21st left arm went weak, brain fog, and confusion intensified, dizziness/spinning, gums, tip of tongue and jawline numb.  Hives on jawline including cobblestone red rash, Headache borderline migraine.  Stumbling, legs weakened and went numb, I could not stand.  Called 911.  UC  intravenous diazapam for muscle spasms, blood draw, performed cat scan on legs , brain and spine MRI, referred to neurologist.
Patient started experiencing fatigue, Joint Pain, Generalized inflammation throughout the body, along with head pain upon using her eyes especially to read. Started experiencing difficulty concentrating and retaining information.
This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Product administration error) and PRODUCT STORAGE ERROR (Product storage error) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Product administration error) and PRODUCT STORAGE ERROR (Product storage error). On 02-Jun-2021, PRODUCT ADMINISTRATION ERROR (Product administration error) and PRODUCT STORAGE ERROR (Product storage error) had resolved. Concomitant medications were not provided by the reporter. On  01-Jun-2021, six vials were moved out of the freezer in to a refrigerator. During transportation of the vials, the temperature in portable refrigerator which contained the vials dropped down to 35.5F and then to 15.1F. The vials were under the recommended temperature of 36 to 45 F for almost 1 hour. On 02-Jun-2021, the local vaccination center who received those six vials, administered 30 doses in to 30 patients from three of the vials. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up received on 01-JUL-2021 included no new information.
Admitted to the hospital for infected sacral decubitus, tested twice during admission and results were negative. Tested a 3rd time per routine prior to surgery and results were positive for Covid on the 14th day of admission.  Remdesivir started on 9/15/21. It is unknown when the patient received his vaccinations.
Vaccine expired 5/28/22, was administered 5/31/22. No adverse reactions noted per patient's mother.
Patient reported itchy throat and increased heart rate (P 111) within 15 minutes of vaccination.  Given Benedryl; symptoms improved and patient released to home.
Headache & NauseaVomiting Per nursing report: "2nd dose of COVID 19 vaccine on 1/27/21. Reports symptoms on 1/28 and 1/29 but came to work. Stated that his symptoms persisted thru today. Complains of nausea and constant headache. Called in from work 2/1 and 2/2"
Post menopausal bleeding; This is a spontaneous report from a contactable consumer (patient) reported that a 54-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8737), via an unspecified route of administration, administered in arm left on 03Apr2021 10:00 (at the age of 54-years-old) as a single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history included IBS (irritable bowel syndrome) and gallbladder removal both from an unknown date. The patient had known allergies to sulfa medicines. No covid prior vaccination. Not tested for covid post vaccination. No other vaccines in four weeks. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207), via an unspecified route of administration, administered in arm left on 13Mar2021 10:00 (at the age of 54-years-old) as a single dose for covid-19 immunisation. The patient's concomitant medications were not reported. On 03Apr2021 12:00 PM, the patient experienced post menopausal bleeding. No treatment was provided for the event. The event was resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The outcome of the event was recovered.
PT C/O SOB, AND WAS GRABBING HER THROAT, VS OBTAINED AND PT PLACED ON COTT, HR 150, R 18, BP 131/78, SAT 94%, PT OBSERVED TO BE HAVING SEVERE ANXIETY.  REASSURED PT AND ASSESSMENT COMPLETED.  LUNGS CLEAR, COLOR PINK.  NO RESP DISTRESS NOTED.  911 CALLED.  FIRE DEPT ARRIVED WITHIN 10 MINS.  VSS ON RA, HR 125, RESP 18, BP 130/75, O2SAT 99J%.  EMTS ASSUMED CARE, AND PROVIDED REASSURANCE TO PT.  EMTS CLEARED PT AS STABLE  PT WAS ABLE TO CALM DOWN AND LEFT IN STABLE CONDITION WITH HER SPOUSE WHO DROVE HER HOME.   NO DISTRESS NOTED UPON DEPARTURE
She went to work for 2hrs and had to come home.; Threw up; She felt nauseous; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She went to work for 2hrs and had to come home.), DISCOMFORT (Threw up), NAUSEA (She felt nauseous), CHILLS (Chills) and HEADACHE (Headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Bladder disorder (She has a bladder disorder and takes meds for that.). Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL (TYLENOL PM) for an unknown indication.    On 09-Feb-2021 at 1:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced FEELING ABNORMAL (She went to work for 2hrs and had to come home.), DISCOMFORT (Threw up), NAUSEA (She felt nauseous), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, FEELING ABNORMAL (She went to work for 2hrs and had to come home.), DISCOMFORT (Threw up), NAUSEA (She felt nauseous), CHILLS (Chills) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient take took 2 Tylenol PM and a migraine pill and Anti nauseous pill.  Patient take Medication for bladder disorder
Pt developed severe fevers, myalgias, headache, inability to take PO day after vaccine, developed significant AKI and required hospitalization - overnight observation. Was hospitalized 2/23 - 2/24 and had resolution of symptoms, improvement in AKI and was stable for discharge home.
Case received primary Covid vaccine series in Feb 2021, then was hospitalized for Covid in January 2022. Hospitalized at: Hospital. Pneumonia due to COVID-19 virus. Assessment & Plan Vaccinated patient, tested positive on Admission. Hypoxic on admission but this is her baseline per daughter (normally 84%). Got one day of dexamethasone but given that this is likely asymptomatic infection, we have stopped for now. Family does not want remdesivir. Home oxygen evaluation done as patient likely needs oxygen at baseline given history, qualified for 2L   - COVID precautions through 1/27/21 - Continue home inhalers
did not receive dose 3 yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix B (1st dose received on an unknown date) and Engerix B (2nd dose received in June 2021).   On an unknown date, the patient did not receive the 3rd dose of Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 17-NOV-2022 Reporter's comment: Pharmacist stated that the patient received dose one, then dose two in June 2021, but due to being displaced by a hurricane did not receive dose 3 yet.  No further information was available on call. The reporter consented to follow-up. Additional Supportive Information: Till the time of reporting the patient did not receive the 3rd dose of Engerix B, which led to Incomplete course of vaccination.
Arm was sore. Exactly a week later area where injection was given was swollen and itching with heat. At this point it?s still swollen and itching  has not gotten better.
Was reported to me that by the teacher at the school where patient had received her vaccine, that patient had returned to class that afternoon and was becoming short of breath. Went to her doctors office. they gave her Benadryl and steroids.
Headache, dizziness, abdominal pain. Monitored in clinic for one hour before feeling better.
prickles like pins and needles/Paraesthesia; This case was reported by a consumer via call center representative and described the occurrence of pins and needles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2021, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, several days after receiving Shingrix, the patient experienced pins and needles. On an unknown date, the outcome of the pins and needles were not recovered/not resolved.   It was unknown if the reporter considered the pins and needles to be related to Shingrix.     Additional Information: GSK Receipt Date: 28-APR-2022 Reporter's comment: The patient was the reporter. He received his first Shingrix dose on left arm.  An unknown number of days later he developed prickles like pins and needles sensation to his left upper torso including left shoulder and left side of neck (paresthesia). The paresthesia comes and goes. It was worse at night, especially if he lies on his left side. He has nothing else to report. The reporter declined to provide his email address. The reporter consented to follow up with health care professional but declined to provide MD's contact information, including name.
pt lt leg became swollen-entire length of leg; pt refused to walk because of pain & swelling; fever to 103 w/APAP given every 4 hrs; mom switched to Advil p/36 hrs of APAP p/which sx subsided; Reporter states lt thigh 1" larger than rt;
Dizziness approx 5pm.  Stumbling & trouble walking approx 5:30pm- felt eyes rolling back, eyes were fluttering for approx 5min, extreme malaise, fell asleep- next am felt  fine
This spontaneous report received from a consumer, concerned a male of unspecified age. Medical history, weight, height, concomitant medications and concurrent conditions not reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch/lot number: not reported) dose, start therapy date: not reported, for immunization. Unable to perform follow-up to request batch/lot numbers. On an unspecified date, patient experienced an adverse reaction with the COVID-19 vaccine. The action taken with COVID-19 vaccine ad26.cov2.s: not applicable. The outcome of adverse reaction with the COVID-19 vaccine: not reported.
Nausea; Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "Nausea"; DIARRHOEA (non-serious), outcome "unknown", described as "Diarrhea".  Additional information: A husband called for his wife, Patient got the Covid vaccine and explained that got the shot on Wednesday and has had nausea and diarrhea and he was wondering what over the counter product she can take for this.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No additional AE; Patient who was previously administered with VARlV AX was inadvertently administered PROQUAD; Healthcare Professional had Just saw MMR' lettering from PROQUAD; This spontaneous report has been received from a physician, referring to a 12 months-old male patient. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug and allergy reactions was unknown by the reporter.  On an unknown date (reported as: previously administered), the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX). On 02-JUL-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strengths, formulations, doses, route of  administration, anatomical location of administrations, lot numbers and expiration dates were not provided for both suspect vaccines) both of them administered as prophylaxis. Consequently on the same day, the healthcare professional had "just saw MMR lettering" from the suspect vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (product label confusion); therefore, the vaccine was inadvertently administered to the patient (wrong product administered). No additional adverse event were reported.
Patient called Public Health Center 9/13/21 to inquire where she can get assistance for a vaccine related adverse event as she is uninsured. She was given the web site.  She reports feeling heart palpations starting the day after and ongoing on and off after receiving 1st Moderna vaccine on Aug 10th from local pharmacy.  She reports having this on and off for extended time but attributed it to anxiety.  After her 2nd dose, Sept 7th from the same Pharmacy, the next day she reported having chest pain on and off ongoing. Then she began feeling dizziness. At this point she realized that this was not within normal for her.  She said that?s when she realized that her symptoms coincided with receiving the vaccine.  She is uninsured 30yo mother of breast feeling infant.  She inquired where to get services. She was directed to Qualified health care clinic. She was read the data safety sheet and instructed to get immediate medical care if she began feeling chest pain, shortness of breath and heart palpations. At the time of this call she was not experiencing symptoms but due to their coming and going nature she thought it best to be evaluated.  I informed her I would be making a VAERS report.
Patient reported severe myalgias and weakness beginning at 11pm. These symptoms have persisted through present 11/5 11:30am. Patient also reported that early this morning at 1am he awoke in a cold sweat.
Numbness to hands and feet; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPOAESTHESIA (non-serious), outcome "unknown", described as "Numbness to hands and feet".  Additional information: The reporter was a pharmacist calling on behalf of a female patient who reported having numbness to hands and feet for the last couple of months after receiving the Pfizer Covid vaccine series, the patients doctors could not figure out what it was. The patients questioned that if she should have the booster dose since she has had these side effects. The reporter did not have any additional information about the patient.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from an 82 year old female patient with penicillin allergy reporting on herself. The patient's pertinent medical history included herpes zoster. On 18-FEB-2015, the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot # and expiry date were not provided). Co-suspect therapies and concomitant medications were not provided. On approximately 26-OCT-2015, reported as "the last week" the patient developed shingles. The patient self-diagnosed and returned to the pharmacy to confirm. The patient had discoloration, redness, swelling and itchiness on her face base of scalp, and ear area about the size of an egg. The patient indicated that she was sure of her diagnosis as she had had shingles in the past, prior to receiving the ZOSTAVAX dose on 18-FEB-2015. No laboratory diagnostic test was performed. The patient did not seek medical attention. At the time of the report, the patient had not recovered from shingles. The relatedness between the event and suspect therapy was not provided. Additional information has been requested.
st dose more than 6 months ago, 2nd not recived; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date ).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 12-OCT-2022 Reporter's Comment: The reporter was patient's friend. The patient did not receive the second dose of Shingrix and it had been longer than six months since his first dose of Shingrix. The reporter stated that he was going to try and convince the patient to receive the second dose. The reporter did not consent to follow up. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
Patient was referred to the hospital by outpatient physician because of a lab abnormality. Serum Creatinine was around 17 mg/dL with a reported baseline around 2mg/dL. She was initiated on hemodialysis, which she never had before, and was considered HD dependent on discharge to a rehab facility. Also treated with a tapering course of high dose corticosteroids. After a length of stay around 12 days, the patient was discharged to an acute rehab facility where she remains.
In the Corona period had been vaccinated three times with the Moderna vaccine against COVID 19 and this year had almost no hay fever; This spontaneous case was reported by a patient and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (In the Corona period had been vaccinated three times with the Moderna vaccine against COVID 19 and this year had almost no hay fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Hay fever (Suffered since childhood. Not very severe but for about 2 - 3 weeks a year.).   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (In the Corona period had been vaccinated three times with the Moderna vaccine against COVID 19 and this year had almost no hay fever). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (In the Corona period had been vaccinated three times with the Moderna vaccine against COVID 19 and this year had almost no hay fever) outcome was unknown.            No concomitant medications were reported  No treatment drugs were reported  Reporter questioned regarding positive side effects of moderna and did have something to do with mRNA vaccine against COVID 19.
after sitting for 15 minutes patient said she had a "pricking dull pain in her neck. She stated it started with her arm which was then ok and moved to her neck. I spoke with patient  roughly 2 hours after for follow up and patient stated was easing.
pains; she feels so sick; She started to fade, she started to feel heavy working with the patients; Achy everywhere; Headache; Chills; Feeling tired; Fever 103F; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN (pains), ILLNESS (she feels so sick), FEELING ABNORMAL (She started to fade, she started to feel heavy working with the patients), MYALGIA (Achy everywhere) and HEADACHE (Headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN (pains), ILLNESS (she feels so sick), FEELING ABNORMAL (She started to fade, she started to feel heavy working with the patients), MYALGIA (Achy everywhere), HEADACHE (Headache), CHILLS (Chills), FATIGUE (Feeling tired) and PYREXIA (Fever 103F). The patient was treated with PARACETAMOL (TYLENOL) for Pyrexia, at an unspecified dose and frequency. On 05-Feb-2021, PYREXIA (Fever 103F) had resolved. At the time of the report, PAIN (pains), ILLNESS (she feels so sick), FEELING ABNORMAL (She started to fade, she started to feel heavy working with the patients), MYALGIA (Achy everywhere), HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Feeling tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: high (High) 103F. On 05-Feb-2021, Body temperature: high (High) 101F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Significant FU received on 12 Jul 2021, reporter information, lab data, outcome of event(pyrexia), new event :feeling abnormal updated.